Finasteride


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000072660 Teratozoospermia PMID:33003968
MESH:D000740 Anemia PMID:10233450
MESH:D001746 Bladder Exstrophy PMID:15530334
MESH:D001927 Brain Diseases PMID:20486040
MESH:D003866 Depressive Disorder PMID:17026771
MESH:D005832 Genital Diseases, Male PMID:20049201
MESH:D006177 Gynecomastia PMID:15151957; PMID:8881946
MESH:D006505 Hepatitis PMID:17298197
MESH:D007172 Erectile Dysfunction PMID:11583366; PMID:8881946; PMID:8911291
MESH:D007333 Insulin Resistance PMID:39265715
MESH:D009135 Muscular Diseases PMID:9121510
MESH:D009845 Oligospermia PMID:33003968; PMID:38216069
MESH:D011297 Prenatal Exposure Delayed Effects PMID:31454150
MESH:D011469 Prostatic Diseases PMID:31454150
MESH:D012734 Disorders of Sex Development PMID:20049201
MESH:D012735 Sexual Dysfunction, Physiological PMID:11583366; PMID:12639651; PMID:12670567; PMID:7544731
MESH:D013226 Status Epilepticus PMID:20437568
MESH:D013733 Testicular Diseases PMID:33003968; PMID:38216069
MESH:D015430 Weight Gain PMID:39265715

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.